The Rapid Induction of Human Riboflavin Deficiency with Galactoflavin

^{Department of Pharmacology, Baylor University College of Medicine, Houston, Texas}

^{Department of Medicine, Baylor University College of Medicine, Houston, Texas}

^{Veterans Administration Hospital, Houston, Texas}

^{National Cancer Institute, Bethesda, Md.}

Markle Scholar in Academic Medicine. Present address: Department of Medicine, Duke University, Durham, N. C.

Submitted for publication June 3, 1963; accepted November 5, 1963.

This investigation was supported in part by U. S. Public Health Service research grant CA 0-5630 from the National Cancer Institute and by the Anna Fuller Fund.

Find articles by Lane, M. in: JCI | PubMed | Google Scholar

^{Department of Pharmacology, Baylor University College of Medicine, Houston, Texas}

^{Department of Medicine, Baylor University College of Medicine, Houston, Texas}

^{Veterans Administration Hospital, Houston, Texas}

^{National Cancer Institute, Bethesda, Md.}

Markle Scholar in Academic Medicine. Present address: Department of Medicine, Duke University, Durham, N. C.

Submitted for publication June 3, 1963; accepted November 5, 1963.

This investigation was supported in part by U. S. Public Health Service research grant CA 0-5630 from the National Cancer Institute and by the Anna Fuller Fund.

Find articles by Alfrey, C. in: JCI | PubMed | Google Scholar

^{Department of Pharmacology, Baylor University College of Medicine, Houston, Texas}

^{Department of Medicine, Baylor University College of Medicine, Houston, Texas}

^{Veterans Administration Hospital, Houston, Texas}

^{National Cancer Institute, Bethesda, Md.}

Markle Scholar in Academic Medicine. Present address: Department of Medicine, Duke University, Durham, N. C.

Submitted for publication June 3, 1963; accepted November 5, 1963.

This investigation was supported in part by U. S. Public Health Service research grant CA 0-5630 from the National Cancer Institute and by the Anna Fuller Fund.

Find articles by Mengel, C. in: JCI | PubMed | Google Scholar

^{Department of Pharmacology, Baylor University College of Medicine, Houston, Texas}

^{Department of Medicine, Baylor University College of Medicine, Houston, Texas}

^{Veterans Administration Hospital, Houston, Texas}

^{National Cancer Institute, Bethesda, Md.}

Markle Scholar in Academic Medicine. Present address: Department of Medicine, Duke University, Durham, N. C.

Submitted for publication June 3, 1963; accepted November 5, 1963.

This investigation was supported in part by U. S. Public Health Service research grant CA 0-5630 from the National Cancer Institute and by the Anna Fuller Fund.

Find articles by Doherty, M. in: JCI | PubMed | Google Scholar

^{Department of Pharmacology, Baylor University College of Medicine, Houston, Texas}

^{Department of Medicine, Baylor University College of Medicine, Houston, Texas}

^{Veterans Administration Hospital, Houston, Texas}

^{National Cancer Institute, Bethesda, Md.}

Markle Scholar in Academic Medicine. Present address: Department of Medicine, Duke University, Durham, N. C.

Submitted for publication June 3, 1963; accepted November 5, 1963.

This investigation was supported in part by U. S. Public Health Service research grant CA 0-5630 from the National Cancer Institute and by the Anna Fuller Fund.

Find articles by Doherty, J. in: JCI | PubMed | Google Scholar